Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.

Programmed cell death (or apoptosis) is a physiological process essential to the normal development and homeostatic maintenance of the immune system. The Fas/Apo-1 receptor plays a crucial role in the regulation of apoptosis, as demonstrated by lymphoproliferation in MRL-lpr/lpr mice and by the recently described autoimmune lymphoproliferative syndrome (ALPS) in humans, both of which are due to mutations in the Fas gene. We describe a novel family with ALPS in which three affected siblings carry two distinct missense mutations on both the Fas gene alleles and show lack of Fas-induced apoptosis. The children share common clinical features including splenomegaly and lymphadenopathy, but only one developed severe autoimmune manifestations. In all three siblings, we demonstrated the presence of anergic CD3+CD4-CD8- (double negative, [DN]) T cells; moreover, a chronic lymphocyte activation was found, as demonstrated by the presence of high levels of HLA-DR expression on peripheral CD3+ cells and by the presence of high levels of serum activation markers such as soluble interleukin-2 receptor (slL-2R) and soluble CD30 (sCD30).

[1]  C. Goodnow,et al.  Autoimmunity: The Fas track , 1995, Current Biology.

[2]  C. Thompson,et al.  CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.

[3]  Warren Strober,et al.  Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.

[4]  F. Rieux-Laucat,et al.  Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. , 1995, Science.

[5]  T. Giese,et al.  In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes. , 1995, Journal of immunology.

[6]  A. Strasser,et al.  Life and death during lymphocyte development and function: evidence for two distinct killing mechanisms. , 1995, Current opinion in immunology.

[7]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[8]  R. Eisenberg,et al.  The abnormal lpr double-negative T cell fails to proliferate in vivo. , 1995, Clinical immunology and immunopathology.

[9]  J. Mountz,et al.  Characterization of human Fas gene. Exon/intron organization and promoter region. , 1995, Journal of immunology.

[10]  M. Peter,et al.  The Role of APO‐1‐Mediated Apoptosis in the Immune System , 1994, Immunological reviews.

[11]  A. Abbas,et al.  Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. , 1994, Current opinion in immunology.

[12]  Y. Laouar,et al.  In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells. , 1994, Journal of immunology.

[13]  S. Nagata,et al.  Purification and characterization of the Fas-ligand that induces apoptosis , 1994, The Journal of experimental medicine.

[14]  Takashi Suda,et al.  Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family , 1993, Cell.

[15]  L. Tartaglia,et al.  A novel domain within the 55 kd TNF receptor signals cell death , 1993, Cell.

[16]  R. Budd,et al.  CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor. , 1993, Journal of immunology.

[17]  S. Kanner,et al.  CD4, CD8 and the role of CD45 in T-cell activation. , 1993, Current opinion in immunology.

[18]  S. Nagata,et al.  A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. , 1993, The Journal of biological chemistry.

[19]  P. Möller,et al.  Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. , 1992, Journal of immunology.

[20]  E. Jaffe,et al.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. , 1992, The Journal of clinical investigation.

[21]  M. Pawlita,et al.  Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. , 1992, The Journal of biological chemistry.

[22]  O. Olerup,et al.  HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. , 1992, Tissue antigens.

[23]  N. Copeland,et al.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis , 1992, Nature.

[24]  N. Copeland,et al.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. , 1992, Journal of immunology.

[25]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[26]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[27]  Eric O Long,et al.  A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis , 1991, The Journal of experimental medicine.

[28]  J. Imboden,et al.  Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice. , 1990, Journal of immunology.

[29]  E. Harris,et al.  Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. , 1990, American journal of clinical pathology.

[30]  M. Tomita-Yamaguchi,et al.  Constitutive turnover of inositol-containing phospholipids in B220+ T cells from autoimmune-prone MRL-lpr/lpr mice. , 1990, Journal of immunology.

[31]  H. Ikeda,et al.  A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse , 1990, The Journal of experimental medicine.

[32]  E. Yeh,et al.  Defective signal transduction in CD4-CD8- T cells of lpr mice. , 1989, Cellular immunology.

[33]  P. Möller,et al.  Monoclonal antibody-mediated tumor regression by induction of apoptosis. , 1989, Science.

[34]  D. Katz,et al.  Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2 , 1981, The Journal of experimental medicine.

[35]  Melvin Cohn,et al.  A Theory of Self-Nonself Discrimination , 1970, Science.

[36]  S. Nagata,et al.  Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.

[37]  J. Russell,et al.  Activation-induced death of mature T cells in the regulation of immune responses. , 1995, Current opinion in immunology.

[38]  P. Linsley,et al.  The role of the CD28 receptor during T cell responses to antigen. , 1993, Annual review of immunology.

[39]  L. Imberti,et al.  Analysis of amplified T cell receptor V beta transcripts by a non-isotopic immunoassay. , 1992, Journal of immunological methods.

[40]  R. Schwartz,et al.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. , 1989, Annual review of immunology.

[41]  D. Nemazee,et al.  The lymphoproliferating cells of MRL‐lpr/lpr mice are a polyclonal population that bear the T lymphocyte receptor for antigen , 1985, European journal of immunology.